Posted in | News | Nanofabrication

Midatech Receives IMP License to Produce Biocompatible Nanoparticles

Midatech Biogune, an auxiliary company of the Midatech Group, has declared that it has received an Investigational Medicinal Products (IMP) License to produce nanoparticles of clinical quality at its advanced facility in Bilbao, Spain. The company received the IMP License from the Spanish Medicines Agency. The company designs, develops, and produces nanomedicines.

An inspection was conducted at the company’s Spain facility on the 15th and 16th of February 2011 and received the accreditation from the Spanish Medicines Agency. Under the latest European regulations, Midatech became one of the first companies to receive the IMP license in Spain.

The biocompatible nanoparticles, manufactured by Midatech, feature several unique properties to suit therapeutic and diagnostic applications. The nanoparticles dissolve in water and diffuse without restraint in vivo. It is also possible to target particular cells using nanoparticles .Unbound nanoparticles with a diameter of five nm or less can be flushed out quickly by the kidneys thus lowering the probability of non-specific in vivo accumulation of nanoparticles.

When multiple ligands are attached to the surface of nanoparticles, it can be useful in multi-drug delivery or multivalent drug delivery on a single particle.

Source: http://www.midatechgroup.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 12). Midatech Receives IMP License to Produce Biocompatible Nanoparticles. AZoNano. Retrieved on April 16, 2024 from https://www.azonano.com/news.aspx?newsID=22580.

  • MLA

    Chai, Cameron. "Midatech Receives IMP License to Produce Biocompatible Nanoparticles". AZoNano. 16 April 2024. <https://www.azonano.com/news.aspx?newsID=22580>.

  • Chicago

    Chai, Cameron. "Midatech Receives IMP License to Produce Biocompatible Nanoparticles". AZoNano. https://www.azonano.com/news.aspx?newsID=22580. (accessed April 16, 2024).

  • Harvard

    Chai, Cameron. 2019. Midatech Receives IMP License to Produce Biocompatible Nanoparticles. AZoNano, viewed 16 April 2024, https://www.azonano.com/news.aspx?newsID=22580.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.